Amazon Prime shipping containers stack up at the Port of Seattle in advance of the 2021 holiday season. (GeekWire Photo / Todd Bishop) Will consumers order up healthcare through Amazon Prime as easily as they stream The Boys or buy an Echo speaker? That’s one question raised by Amazon’s planned $3.9 billion acquisition of One…
Category Archives: Health/Life Sciences
Larry Corey (left) speaks with Anthony Fauci at the Fred Hutchinson Cancer Center. (Fred Hutch Photo) Anthony Fauci, President Biden’s chief medical advisor and a leader of the country’s COVID-19 response, made a pit stop in Seattle for a fireside chat at Fred Hutchinson Cancer Center and to throw the first pitch at Tuesday night’s…
SEngine CEO and chief scientific officer Carla Grandori. (SEngine Photo) Seattle startup SEngine Precision Medicine has raised $10 million to propel drug discovery and development and advance its test that tailors drugs to cancer patients. SEngine cultures patient cancer cells from a biopsy or other material and measures the response to an array of potential…
Sean McClain, Absci founder and CEO. (Absci Picture) Vancouver, Wash.-based drug design and growth firm Absci laid off workers Tuesday, just a little greater than a 12 months after going public. “The macro-economic situations of the previous couple of months prompted us to have interaction in a complete enterprise evaluation to focus the corporate on…
HDT Bio CEO Steve Reed. (HDT Bio Photo) Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a nearly $1.8 million grant from the U.S. Army. “We hope to address not only disease progression, but transmission,” chief operating officer Christopher Pirie told GeekWire. HDT Bio’s…
A new regulatory filing details Amazon’s behind-the-scenes talks for One Medical, leading up to the Seattle tech giant’s agreement to acquire the primary care company for $3.9 billion, announced by the companies July 21. The filing confirms that Amazon wasn’t alone in bidding for One Medical. Identified only as “Party A” in the filing by…
Monod Bio co-founders, from left: David Shoultz, Daniel-Adriano Silva, and Alfredo Quijano Rubio. (Monod Photo) The news: Monod Bio raised $25 million to develop molecular biosensors that light up when they bind their target. The sensors can be designed to detect molecules linked to disease and they also have potential for industrial applications. The origins: Monod’s…
EMulate Therapeutics CEO Chris Rivera. (Emulate Photograph) EMulate Therapeutics, a 20-year-old Bellevue, Wash.-based firm creating radio frequency vitality know-how to deal with a spread of illnesses, filed to go public Tuesday. The 7-person firm, beforehand referred to as Nativis, has applications for aggressive varieties of mind tumors, ache administration, PTSD, ADHD, anxiousness and melancholy. The…
Pattern Computer’s ProSpectral device for detecting COVID-19. (Pattern Computer Photo) A Seattle-area startup called Pattern Computer is developing a rapid COVID-19 test based on patterns in light from spit, one of several projects moving ahead from the 7-year-old company that designed its own computer from scratch. The company’s “Pattern Discovery Engine” was created specifically to discover and…
Nortis, a Seattle-area startup based in 2011 that markets “organ-on-a-chip” know-how, has raised $6 million, in keeping with an SEC submitting. The corporate’s microfluidic chips foster the expansion of human cells in ways in which resemble organs, and have been used to create kidney, liver, blood vessel, coronary heart, gut, and tumor fashions for researchers….